|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/15/24 China Pharma Holdings, Inc. 10-Q 3/31/24 67:3.8M EdgarAgents LLC/FA
5/8/24 China Pharma Holdings, Inc. 8-K:4 5/7/24 10:191K EdgarAgents LLC/FA
4/17/24 Streeterville Capital LLC SC 13G 1:94K SuperCom Ltd. Broadridge Fin’l… Inc/FA
John M. Fife³
Streeterville Management LLC³
4/1/24 China Pharma Holdings, Inc. 10-K 12/31/23 79:10M EdgarAgents LLC/FA
3/29/24 China Pharma Holdings, Inc. 8-K:8 3/27/24 10:185K EdgarAgents LLC/FA
2/23/24 China Pharma Holdings, Inc. 8-K:7,9 2/23/24 11:196K EdgarAgents LLC/FA
2/14/24‡ China Pharma Holdings, Inc. EFFECT 2/14/24 1:2K SEC #5
2/14/24 China Pharma Holdings, Inc. CORRESP¶ 3/14/24 1:9K EdgarAgents LLC/FA
2/8/24 China Pharma Holdings, Inc. 8-K:1,3 2/2/24 10:191K EdgarAgents LLC/FA
2/6/24 China Pharma Holdings, Inc. CORRESP¶ 3/14/24 1:14K EdgarAgents LLC/FA
2/6/24 China Pharma Holdings, Inc. S-3/A 2:549K EdgarAgents LLC/FA
1/26/24 Liu Tao (Chengdu) SC 13G 1:50K China Pharma Holdings, Inc. EdgarAgents LLC/FA
1/26/24 Liu Tao (Chengdu) 3 10% Owner² 1:4K China Pharma Holdings, Inc. EdgarAgents LLC/FA
1/25/24 SEC UPLOAD¶ 3/14/24 2:44K China Pharma Holdings, Inc.
1/12/24 China Pharma Holdings, Inc. S-3 4:497K EdgarAgents LLC/FA
1/12/24 Streeterville Capital LLC SC 13G/A 1:96K China Pharma Holdings, Inc. Broadridge Fin’l… Inc/FA
John M. Fife³
Streeterville Management LLC³
12/21/23 China Pharma Holdings, Inc. 8-K:1,3 12/15/23 10:188K EdgarAgents LLC/FA
12/20/23 Streeterville Capital LLC SC 13G 1:96K Canaan Inc. Broadridge Fin’l… Inc/FA
John M. Fife³
Streeterville Management LLC³
12/19/23 China Pharma Holdings, Inc. 8-K:5,8 12/15/23 10:198K EdgarAgents LLC/FA
12/6/23 Streeterville Capital LLC SC 13G/A 1:96K Dunxin Financial Holdings Ltd. Broadridge Fin’l… Inc/FA
John M. Fife³
Streeterville Management LLC³
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Types: | | 3 | Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-K | Annual Report — Form 10-K. | | 10-Q | Quarterly Report — Form 10-Q. | | CORRESP | Comment-Response or Other Letter to the SEC. | | EFFECT | SEC Notice of Effectiveness. | | S-3 | Registration Statement – Securities for a Transaction — Form S-3. | | SC 13G | Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G. | | UPLOAD | Comment or Other Letter from the SEC. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | | ¶ | This Filing contains a delayed-release Document. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|